|

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

RECRUITINGN/ASponsored by Albert Einstein College of Medicine
Actively Recruiting
PhaseN/A
SponsorAlbert Einstein College of Medicine
Started2023-03-31
Est. completion2027-12
Eligibility
Age18 Years – 64 Years
Healthy vol.Accepted
Locations2 sites

Summary

This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.

Eligibility

Age: 18 Years – 64 YearsHealthy volunteers accepted
Inclusion Criteria:

* Type 1 diabetes (T1D) duration ≥ 6 months
* 18-64 years old
* English- or Spanish-speaking
* Anxiety or depressive mood disorder as per structured diagnostic interview.

Exclusion Criteria:

* Developmental or sensory disability interfering with participation
* Current pregnancy
* Bipolar disorders, psychotic disorders, severe eating disorders, severe substance abuse disorders, or acute suicidal risk or self-harm
* Use of medications or recent medical procedures that would impact glycemic control or use of continuous glucose monitoring (CGM) over the study
* Received cognitive behavioral therapy (CBT) in last year or plans to initiate CBT; (6) temporary exclusion for recent initiation of psychotropic medication - must be on a stable dose for 6 weeks prior to enrollment.

Conditions4

AnxietyDepressionDiabetesType 1 Diabetes

Locations2 sites

Massachusetts

1 site
Boston University
Boston, Massachusetts, 02215
Todd Farchione, PhDtfarchio@bu.edu

New York

1 site
Albert Einstein College of Medicine
The Bronx, New York, 10461
Keyla Ordonez, BS631-747-9325keyla.ordonez@einsteinmed.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.